Related Experiment Video
Updated: Nov 9, 2025

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
Reduced antioxidant capacity in children with iron deficiency and iron-deficiency anemia
Humeyra Aslaner1, Mehmet Akif Dündar2, Alev Arslan3
1Department of Pediatrics, Medical Health University Kayseri Training and Research Hospital, Kayseri, Turkey.
Insights
Iron deficiency anemia (IDA) and iron deficiency (ID) in adolescents are linked to increased carotid intima-media thickness (CIMT) and reduced antioxidant enzymes. Early iron treatment is crucial to prevent atherosclerotic changes.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Nutritional Biochemistry
Background:
- Adolescent iron deficiency anemia (IDA) and iron deficiency (ID) are prevalent nutritional concerns.
- Reduced antioxidant capacity is implicated in the pathogenesis of various chronic diseases.
Purpose of the Study:
- To evaluate the association between antioxidant enzymes (paraoxonase-1, glutathione peroxidase, glutathione reductase) and carotid intima-media thickness (CIMT) in adolescents with ID and IDA.
- To investigate the impact of iron deficiency on atherosclerosis susceptibility.
- To assess the effect of iron therapy on antioxidant status and CIMT in IDA patients.
Main Methods:
- Cross-sectional study comparing 25 IDA patients, 25 ID patients, and 21 healthy controls (aged 14-15 years).
- Measurements included serum paraoxonase (PON1), glutathione peroxidase (GSH-Px), glutathione reductase (GSH-R), and carotid intima-media thickness (CIMT).
- Follow-up measurements after 3 months of oral iron therapy in the IDA group.
Main Results:
- Adolescents with ID and IDA exhibited significantly higher CIMT compared to controls.
- Significantly lower activities of PON1, GSH-Px, and GSH-R were observed in IDA patients versus controls.
- Serum PON1 activity was also significantly lower in ID patients compared to controls.
- Iron therapy normalized PON1, GSH-Px, and GSH-R activities in IDA patients.
Conclusions:
- Decreased antioxidant capacity in adolescents with ID and IDA contributes to atherosclerotic changes.
- Prompt treatment of iron deficiency is essential to mitigate cardiovascular risks and prevent the progression to IDA.
Objective:
This study aimed to assess the relationship between antioxidant enzymes such as glutathione peroxidase (GSH-Px), glutathione reductase (GSH-R), and paraoxonase (PON1) and carotid intima-media thickness (CIMT) and investigate susceptibility to atherosclerosis with decreasing antioxidant capacity in adolescent patients with iron deficiency (ID) and irondeficiency anemia (IDA).
Material And Methods:
Twenty-five patients with IDA (14.9±1.8 years; 14 female and 11 male patients), 25 patients with ID (14.1±2.24 years; 13 female and 12 male patients) and 21 healthy controls (14.04±2.01 years; 11 female and 10 male individuals) were included in the study. Serum PON1, GSH-Px, GSH-R, and CIMT were measured in all cases. After 3-month oral iron therapy for the group with IDA, the same measurements were performed again.
Results:
CIMT was statistically significantly higher in patients with ID and IDA than in the control group (p<0.05). PON1, GSH-Px, and GSH-R activities decreased and were statistically significantly low in patients with IDA compared to the control group (p<0.05). Serum PON1 activity was statistically significantly lower in patients with ID than in the control group (p<0.05). Post-treatment PON1, GSH-Px, and GSH-R activities in patients with IDA got back to normal and were statistically significantly higher compared to pre-treatment values.
Conclusions:
Antioxidant capacity decreases in patients with IDA and ID, which causes atherosclerotic changes. Therefore, patients with iron deficiency must be treated without the development of iron-deficiency anemia.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
The Periodic Table and Organismal Elements
The Periodic Table and Organismal Elements
Periodic Table Provides Information...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

